INVEGA TRINZA paliperidone (as palmitate) 175 mg modified release suspension for injection pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

invega trinza paliperidone (as palmitate) 175 mg modified release suspension for injection pre-filled syringe

janssen-cilag pty ltd - paliperidone palmitate, quantity: 312 mg/ml (equivalent: paliperidone, qty 200 mg/ml) - injection, suspension - excipient ingredients: polysorbate 20; macrogol 4000; citric acid monohydrate; monobasic sodium phosphate monohydrate; sodium hydroxide; water for injections - indicated for the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months.